TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biotech Fluidics AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
9,094
|
6,881
|
5,535 |
Financial expenses |
0
![]() |
0
|
1 |
Earnings before taxes |
1,315
|
1,002
|
410 |
EBITDA |
1,224
|
672
|
344 |
Total assets |
4,125
|
2,923
|
1,965 |
Current assets |
3,696
|
2,453
|
1,538 |
Current liabilities |
1,413
|
878
|
585 |
Equity capital |
2,571
|
1,913
|
1,287 |
- share capital |
9
|
10
![]() |
10 |
Employees (average) |
13
|
12
![]() |
12 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
62.3%
|
65.4%
|
65.5% |
Turnover per employee |
700
|
573
|
461 |
Profit as a percentage of turnover |
14.5%
|
14.6%
|
7.4% |
Return on assets (ROA) |
31.9%
|
34.3%
|
20.9% |
Current ratio |
261.6%
|
279.4%
|
262.9% |
Return on equity (ROE) |
51.1%
|
52.4%
|
31.9% |
Change turnover |
2,770
|
1,449
|
409 |
Change turnover % |
44%
|
27%
|
8% |
Chg. No. of employees |
1
|
0
|
2 |
Chg. No. of employees % |
8%
|
0%
|
20% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.